| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Mrz―12 |
Combination of adenovirus vector and subunit protein elicits a robust immune response against the SARS-CoV-2 Omicron variant |
Chunjun Ye, Xiya Huang, Weiqi Hong, Jie Shi, Danyi Ao, Yu Zhang, Yishan Lu, Yingqiong Zhou, Zhiruo Song, Yu Zhang, Yanyan Liu, Ping Cheng, Guangwen Lu, Jiong Li, Xiangrong Song, Xiawei Wei |
| 2 |
[GO] |
2025―Okt―14 |
Development of a trispecific fusion protein based on angiotensin-converting enzyme 2, glycoprotein 130, and tumor necrosis factor receptor 2 as a promising therapeutic for COVID-19 |
Yongfeng Qiao, Yanjun Han, Lu Zhao, Wenjing Gao, Hong Hu, Chao Su, Anqi Zheng, Junqing Sun, Mingxiong Tian, Yarong Wu, Lianmei Bai, Yuping Lei, Jiahao Wu, Weibing Zhang, Pu Han, Xiaoyu Li, Chunbo Dong, Haidong Wang, Zhida Liu, Pengcheng Han |
| 3 |
[GO] |
2025―Jan―03 |
The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development |
Mayur Suresh Gawande, Nikita Zade, Praveen Kumar, Swapnil Gundewar, Induni Nayodhara Weerarathna, Prateek Verma |
| 4 |
[GO] |
2024―Dez―05 |
Characteristics of the early innate response induced by the aerosolized Ad5-vectored COVID-19 vaccine |
Wan-Ru Zheng, Jun-Yan Dan, Nan Huo, Zhe Zhang, Li-Hua Hou |
| 5 |
[GO] |
2024―Jul―28 |
Assessing the neutralizing antibody and duration of RNA positivity from COVID-19 infected patients with immunocompromised diseases and pneumonia |
Shuo Liu, Xuelian Wu, Ziteng Liang, Weijin Huang, Yufeng Xiong |
| 6 |
[GO] |
2024―Mai―17 |
Effects of different treatments for type 2 diabetes mellitus on mortality of coronavirus disease from 2019 to 2021 in China: a multi-institutional retrospective study |
Ke Xu, Wu He, Bo Yu, Kaineng Zhong, Da Zhou, Dao Wen Wang |
| 7 |
[GO] |
2023―Dez―18 |
Correction: Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses |
Songhao Yang, Liangwei Duan, Chan Wang, Cuiying Zhang, Siyu Hou, Hao Wang, Jiahui Song, Tingting Zhang, Zihua Li, Mingxia Wang, Jing Tang, Qianqian Zheng, Hui Wang, Qi Wang, Wei Zhao |
| 8 |
[GO] |
2023―Nov―07 |
SARS-CoV-2 RNA persists in the central nervous system of non-human primates despite clinical recovery |
Hailong Li, Kristen A. McLaurin, Charles F. Mactutus, Jay Rappaport, Prasun K. Datta, Rosemarie M. Booze |
| 9 |
[GO] |
2023―Okt―19 |
Activation and induction of antigen-specific T follicular helper cells play a critical role in recombinant SARS-CoV-2 RBD vaccine-induced humoral responses |
Songhao Yang, Liangwei Duan, Chan Wang, Cuiying Zhang, Siyu Hou, Hao Wang, Jiahui Song, Tingting Zhang, Zihua Li, Mingxia Wang, Jing Tang, Qianqian Zheng, Hui Wang, Qi Wang, Wei Zhao |
| 10 |
[GO] |
2023―Aug―03 |
Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814 |
Haihai Jiang, Xiaofang Zou, Pei Zeng, Xiangyi Zeng, Xuelan Zhou, Jie Wang, Jin Zhang, Jian Li |
| 11 |
[GO] |
2023―Mai―22 |
Modular characterization of SARS-CoV-2 nucleocapsid protein domain functions in nucleocapsid-like assembly |
Yan Wang, Xiaobin Ling, Chong Zhang, Jian Zou, Bingnan Luo, Yongbo Luo, Xinyu Jia, Guowen Jia, Minghua Zhang, Junchao Hu, Ting Liu, Yuanfeiyi Wang, Kefeng Lu, Dan Li, Jinbiao Ma, Cong Liu, Zhaoming Su |
| 12 |
[GO] |
2023―Mrz―10 |
Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants |
Cai He, Li Chen, Jingyun Yang, Zimin Chen, Hong Lei, Weiqi Hong, Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei |
| 13 |
[GO] |
2022―Dez―12 |
Inhibition of glycogen synthase kinase-3-beta (GSK3β) blocks nucleocapsid phosphorylation and SARS-CoV-2 replication |
Tirosh Shapira, Selvarani Vimalanathan, Celine Rens, Virginia Pichler, Sandra Peña-Díaz, Grace Jordana, William Rees, Dirk F. H. Winkler, Iqbal Sarai, Theodore Steiner, François Jean, Steven Pelech, Yossef Av-Gay |
| 14 |
[GO] |
2022―Nov―28 |
Alterations of the fecal microbiota in relation to acute COVID-19 infection and recovery |
Yue Sandra Yin, Carlos D. Minacapelli, Veenat Parmar, Carolyn C. Catalano, Abhishek Bhurwal, Kapil Gupta, Vinod K. Rustgi, Martin J. Blaser |
| 15 |
[GO] |
2022―Okt―21 |
Identification of a Sialosides binding pocket in early-lineage SARS-CoV-2 via an optimized STD NMR method: a novel explanation for coronavirus virulence and zoonosis |
Geng Chen, Wei Gao, Yang Du |
| 16 |
[GO] |
2022―Jul―15 |
Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity |
Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble, Sathiah Thennarasu |
| 17 |
[GO] |
2022―Jul―05 |
A new strategy: identification of specific antibodies for neutralizing epitope on SARS-CoV-2 S protein by LC-MS/MS combined with immune repertoire |
Meng Yu, Zhu Zhu, Yanqun Wang, Pingzhang Wang, Xiaodong Jia, Jie Wang, Lei Liu, Wanbing Liu, Yaqiong Zheng, Guomei Kou, Weiyan Xu, Jing Huang, Fengmin Lu, Xiajuan Zou, Shangen Zheng, Yinying Lu, Jincun Zhao, Hui Dai, Xiaoyan Qiu |
| 18 |
[GO] |
2022―Jun―02 |
Cleavage of the selective autophagy receptor SQSTM1/p62 by the SARS-CoV-2 main protease NSP5 prevents the autophagic degradation of viral membrane proteins |
Yabin Zhang, Shiyan Liu, Qingjia Xu, Huihui Li, Kefeng Lu |
| 19 |
[GO] |
2022―Mai―20 |
Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19 |
Shuai Yang, Ying Tong, Lu Chen, Wenqiang Yu |
| 20 |
[GO] |
2022―Apr―24 |
Omicron-included mutation-induced changes in epitopes of SARS-CoV-2 spike protein and effectiveness assessments of current antibodies |
Du Guo, Huaichuan Duan, Yan Cheng, Yueteng Wang, Jianping Hu, Hubing Shi |
| 21 |
[GO] |
2022―Feb―17 |
Stem cell therapy for COVID-19 pneumonia |
Maziar Malekzadeh Kebria, Peiman Brouki Milan, Noshad Peyravian, Jafar Kiani, Soheil Khatibi, Masoud Mozafari |
| 22 |
[GO] |
2021―Nov―23 |
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? |
Kavya Srinivasan, Ashutosh Kumar Pandey, Ashlena Livingston, Sundararajan Venkatesh |
| 23 |
[GO] |
2021―Sep―29 |
A promising vaccine candidate against COVID-19 |
Xiwei Wang, Wenwei Tu |
| 24 |
[GO] |
2021―Sep―26 |
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKA |
Yuan Liu, Lianpan Dai, Xiaoli Feng, Ran Gao, Nan Zhang, Bin Wang, Jianbao Han, Qingcui Zou, Xiling Guo, Hua Zhu, Jiangning Liu, Chuan Qin, Yi Zhang, Linlin Bao, Minghua Li |
| 25 |
[GO] |
2021―Sep―19 |
Computationally repurposed drugs and natural products against RNA dependent RNA polymerase as potential COVID-19 therapies |
Sakshi Piplani, Puneet Kumar Singh, David A. Winkler, Nikolai Petrovsky |
| 26 |
[GO] |
2021―Apr―09 |
COVID-19: insights into virus-receptor interactions |
Azadeh Sepahvandi, Maryam Ghaffari, Amir Hossein Bahmanpour, Fathollah Moztarzadeh, Payam Zarrintaj, Hasan Uludağ, Masoud Mozafari |
| 27 |
[GO] |
2021―Mrz―20 |
Disruption of respiratory epithelial basement membrane in COVID-19 patients |
Xue Liu, Yinshan Fang, Paul W. Noble, Jianwen Que, Dianhua Jiang |
| 28 |
[GO] |
2021―Jan―20 |
Immunological perspectives on the pathogenesis, diagnosis, prevention and treatment of COVID-19 |
Yanghong Ni, Aqu Alu, Hong Lei, Yang Wang, Min Wu, Xiawei Wei |
| 29 |
[GO] |
2020―Dez―03 |
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines |
Yinan Xiao, Hanyue Xu, Wen Guo, Yunuo Zhao, Yuling Luo, Ming Wang, Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng, Fushen Sha, Xuelei Ma |
| 30 |
[GO] |
2020―Nov―20 |
SARS-CoV-2 is less likely to infect aquatic food animals: sequence and phylogeny analysis of ACE2 in mammals and fish |
Dong Chen, Yuchen Liu, Huihui Yang, Lisa Liu, Weiren Huang, Yongsheng Zhao |
| 31 |
[GO] |
2020―Aug―19 |
Structural basis for the multimerization of nonstructural protein nsp9 from SARS-CoV-2 |
Changhui Zhang, Yiping Chen, Li Li, Yan Yang, Jun He, Cheng Chen, Dan Su |
| 32 |
[GO] |
2020―Aug―06 |
Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein |
Renjie Zhou, Rui Zeng, Albrecht von Brunn, Jian Lei |
|
